TITLE

Heparanase expression correlates with poor survival in oral mucosal melanoma

AUTHOR(S)
Wang, Xin; Wen, Weiwei; Wu, Heming; Chen, Yi; Ren, Guoxin; Guo, Wei
PUB. DATE
September 2013
SOURCE
Medical Oncology;Sep2013, Vol. 30 Issue 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
89980967

 

Related Articles

  • Increased Levels of β-catenin, LEF-1, and HPA-1 Correlate with Poor Prognosis for Acral Melanoma with Negative BRAF and NRAS Mutation in BRAF Exons 11 and 15 and NRAS Exons 1 and 2. Xu, Sanxiong; Yang, Zuozhang; Zhang, Jinyu; Jiang, Yongxin; Chen, Yongbin; Li, Hongjun; Liu, Xuefeng; Xu, Da; Chen, Yanjin; Yang, Yihao; Zhang, Ya; Li, Dongxu; Xia, Junfeng // DNA & Cell Biology;Jan2015, Vol. 34 Issue 1, p69 

    To determine the expression of β-catenin, lymphoid enhancer-binding protein-1 (LEF-1), and heparanase-1 (HPA-1) and to evaluate these proteins' potential prognostic values in malignant acral melanoma without mutations in BRAF exons 11 and 15 and NRAS exons 1 and 2, specimens from 90 patients...

  • Heparanase expression correlates with malignant potential in human colon cancer. Nobuhisa, T.; Naomoto, Y.; Ohkawa, T.; Takaoka, M.; Ono, R.; Murata, T.; Gunduz, M.; Shirakawa, Y.; Yamatsuji, T.; Haisa, M.; Matsuoka, J.; Tsujigiwa, H.; Nagatsuka, H.; Nakajima, M.; Tanaka, N. // Journal of Cancer Research & Clinical Oncology;Apr2005, Vol. 131 Issue 4, p229 

    Purpose: Heparanase cleaves carbohydrate chains of heparan sulphate proteoglycans and is an important component of the extracellular matrix. This study was designed to determine the relation between heparanase expression and prognosis of patients with colon cancer. Methods: The study included 54...

  • Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence. Doviner, Victoria; Maly, Bella; Kaplan, Victoria; Gingis-Velitski, Svetlana; Ilan, Neta; Vlodavsky, Israel; Sherman, Yoav // Modern Pathology;Jun2006, Vol. 19 Issue 6, p878 

    Heparanase is a mammalian endo-β-D-glucuronidase that cleaves heparan sulfate side chains at a limited number of sites. Such enzymatic activity is thought to participate in degradation and remodeling of the extracellular matrix and to facilitate cell invasion associated with tumor metastasis,...

  • Heparanase Expression in Malignant Salivary Gland Tumors Inversely Correlates with Long-Term Survival. Ben-Izhak, Ofer; Kaplan-Cohen, Victoria; Ilan, Neta; Gan, Shlomit; Vlodavsky, Israel; Nagler, Rafael // Neoplasia;Oct2006, Vol. 8 Issue 10, p879 

    BACKGROUND: Upregulation of the endo-β-D-glucuronidase, heparanase, was noted in an increasing number of human malignancies. Heparanase expression correlated with enhanced local and distant metastatic spread, increased vascular density, and reduced postoperative survival. PATIENTS AND...

  • Development of Heparanase Inhibitors for Anti-Cancer Therapy. Hua-Quan Miao; Hu Liu; Navarro, Elizabeth; Kussie, Paul; Zhenping Zhu // Current Medicinal Chemistry;2006, Vol. 13 Issue 18, p2101 

    Heparanase is an endo-beta-D-glucuronidase that degrades heparan sulfate glycosaminoglycan side chains of the proteoglycans in extracellular matrix and basement membrane. Heparanase enzymatic activity is important in the promotion of tumor angiogenesis, primary tumor growth, invasion, and...

  • Heparanase: Structure, Biological Functions, and Inhibition by Heparin-Derived Mimetics of Heparan Sulfate. Vlodavsky, Israel; Ilan, Neta; Naggi, Annamaria; Casu, Benito // Current Pharmaceutical Design;Jul2007, Vol. 13 Issue 20, p2057 

    Heparanase is an endoglycosidase which cleaves heparan sulfate (HS) and hence participates in degradation and remodeling of the extracellular matrix (ECM). Heparanase is preferentially expressed in human tumors and its over-expression in tumor cells confers an invasive phenotype in experimental...

  • Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas. Veloso, Emerson Soares; Gonçalves, Ivy Nayra Nascimento; Silveira, Tatiany Luiza; Oliveira, Fernando Soares; Vieira, Déborah Soares; Cassali, Geovanni Dantas; Del Puerto, Helen Lima; Ferreira, Enio // BMC Veterinary Research;1/29/2020, Vol. 16 Issue 1, p1 

    Background: The epidermal growth factor receptors participate in the physiological processes such as regulation of morphogenesis, proliferation and cell migration, but when overexpressed or overactivated they may play an important role in neoplastic progression. Melanoma is the most aggressive...

  • Primary Oral Malignant Melanoma: Two Case Reports and Review of Literature. Sharma, Neeraj // Journal of Biomedicine & Biotechnology;2012, Vol. 2012, p1 

    Primary malignant melanoma of the oral cavity is a rare neoplasm. The tumors tend to metastasize or locally invade tissue more readily than other malignant tumors in the oral region. The survival of patients with mucosal melanomas is less than for those with cutaneous melanomas. Tumor size and...

  • Primary Oral Malignant Melanoma: Two Case Reports and Review of Literature. Sharma, Neeraj // Case Reports in Dentistry;2012, p1 

    Primary malignant melanoma of the oral cavity is a rare neoplasm. The tumors tend to metastasize or locally invade tissue more readily than other malignant tumors in the oral region. The survival of patients with mucosal melanomas is less than for those with cutaneous melanomas. Tumor size and...

  • Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Rohloff, J.; Zinke, J.; Tannapfel, A.; Witszigmann, H.; Mossner, J.; Wittekind, C.; Caca, K. // British Journal of Cancer;4/22/2002, Vol. 86 Issue 8, p1270 

    Pancreatic ductal adenocarcinoma has a median survival of less than 6 months from diagnosis. This is due to the difficulty in early diagnosis, the aggressive biological behaviour of the turnout and a lack of effective therapies for advanced disease. Mammalian heparanase is a heparan-sulphate...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics